Fermenta Biotech Ltd (FERMENTA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 261671, "name": "Fermenta Biotec.", "stock_name": "Fermenta Biotec.", "full_name": "Fermenta Biotech Ltd", "name_url": "stocks-analysis/fermenta-biotec", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "328.55", "chg": 1.05, "chgp": "0.32%", "dir": 1, "prev_price": "327.50", "mcapval": "971.00 Cr", "mcap": "Micro Cap", "scripcode": 506414, "symbol": "FERMENTA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE225B01021", "curr_date": "Jun 11, 03:30 PM", "curr_time": "05:27 AM", "last_traded_at": "Jun 11, 03:30 PM IST", "bse_nse_vol": "34.66 k", "exc_status": "Active", "traded_date": "Jun 11, 2026", "traded_date_str": "2026 06 11", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fermenta-biotec-261671-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Fermenta Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-ltd-technical-momentum-shifts-amid-mixed-market-signals-4045760", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FermentaBiotech_technicaldot_4045760.png", "date": "2026-06-11 08:01:10", "description": "Fermenta Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish signals from volume-based indicators, the overall technical landscape suggests caution for investors as key momentum oscillators and moving averages point towards a weakening price trajectory." }, { "title": "Fermenta Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-ltd-technical-momentum-shifts-amid-mixed-market-signals-4043188", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FermentaBiotech_technicaldot_4043188.png", "date": "2026-06-10 08:01:10", "description": "Fermenta Biotech Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a modest day change of 0.26%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This article analyses these technical parameters in detail, placing the stock’s performance in the context of its sector and broader market trends." }, { "title": "Fermenta Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-ltd-technical-momentum-shifts-amid-mixed-market-signals-4035142", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FermentaBiotech_technicaldot_4035142.png", "date": "2026-06-04 08:00:56", "description": "Fermenta Biotech Ltd has experienced a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a modest day gain of 1.15%, the stock’s broader technical signals and market context suggest cautious investor sentiment amid mixed momentum cues." }, { "title": "Fermenta Biotech Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/fermenta-biotech-ltd-is-rated-strong-sell-4033548", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FermentaBiotech_mojoScore_4033548.png", "date": "2026-06-03 10:11:05", "description": "Fermenta Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 April 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 June 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Fermenta Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-ltd-valuation-shifts-signal-renewed-price-attractiveness-4025061", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/FermentaBiotech_valuationdot_4025061.png", "date": "2026-06-01 08:01:17", "description": "Fermenta Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting evolving market perceptions amid a challenging pharmaceutical sector. Despite a modest day gain of 0.68%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more compelling entry point relative to its peers and historical benchmarks." }, { "title": "Fermenta Biotech Declines 2.46% Amid Bearish Technical Signals and Earnings Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-declines-246-amid-bearish-technical-signals-and-earnings-pressure-4024467", "imagepath": "", "date": "2026-05-31 11:00:58", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Stock opens at Rs.302.00, declines despite Sensex rally</p>\n <p><strong>26 May:</strong> Death Cross forms, stock drops 3.77% to Rs.290.60</p>\n <p><strong>27 May:</strong> Q4 FY26 results reveal profit plunge; technical downgrade confirmed</p>\n <p><strong>29 May:</strong> Stock recovers slightly to Rs.295.20 but remains under pressure</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.302.65</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div..." }, { "title": "Are Fermenta Biotech Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-fermenta-biotech-ltd-latest-results-good-or-bad-4017341", "imagepath": "", "date": "2026-05-27 19:39:18", "description": "Fermenta Biotech Ltd's latest financial results for the quarter ended March 2026 indicate significant challenges in operational performance. The company reported consolidated net sales of ₹121.58 crores, reflecting a year-on-year decline of 13.06% from ₹139.85 crores in the same quarter of the previous year. This marks the fourth consecutive quarter of year-on-year revenue decline, with the current quarter showing the steepest drop.\n\nConsolidated net profit also faced substantial pressure, amounting to ₹19.19 crores, which represents a 44.20% decrease compared to the previous year. While there was a sequential recovery in net profit, the year-on-year performance highlights ongoing difficulties in maintaining profitability. The operating profit, excluding other income, fell sharply to ₹20.00 crores, down 45.86% from ₹36.94 crores in the prior year, indicating significant margin compression.\n\nOperating margin..." }, { "title": "Fermenta Biotech Q4 FY26: Profitability Plunges Amid Revenue Decline", "link": "https://www.marketsmojo.com/news/result-analysis/fermenta-biotech-q4-fy26-profitability-plunges-amid-revenue-decline-4017214", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FermentaBiotech_quaterlyResult_4017214.png", "date": "2026-05-27 12:02:10", "description": "Fermenta Biotech Limited, a micro-cap pharmaceutical and biotechnology company, reported a challenging fourth quarter for FY26, with consolidated net profit declining 44.20% year-on-year to ₹19.19 crores from ₹34.39 crores in Q4 FY25. On a sequential basis, however, the company managed a 51.34% quarter-on-quarter recovery from the ₹12.68 crores posted in Q3 FY26. Net sales for the quarter stood at ₹121.58 crores, down 13.06% year-on-year and 11.49% sequentially, marking the lowest quarterly revenue in the past eight quarters." }, { "title": "Fermenta Biotech Ltd Faces Bearish Momentum Amid Technical Downgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-ltd-faces-bearish-momentum-amid-technical-downgrade-4015579", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/FermentaBiotech_technicaldot_4015579.png", "date": "2026-05-27 08:00:55", "description": "Fermenta Biotech Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s stock price has declined by 3.77% today, reflecting growing investor caution amid weakening technical parameters and a downgrade in its overall mojo grade to Strong Sell." } ], "total": 560, "sid": "261671", "stock_news_url": "https://www.marketsmojo.com/news/fermenta-biotech-261671" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "09-Jun-2026", "details": "Intimation for Investor meet on June 15 2026.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "08-Jun-2026", "details": "Intimation of investor meeting of June 12 2026.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation", "datetime": "28-May-2026", "details": "Investor presentation for Q4/FY26", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Fermenta Biotech Ltd has declared <strong>50%</strong> dividend, ex-date: 06 Aug 25", "dt": "2025-08-06", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Fermenta Biotech Ltd has announced <strong>5:5</strong> stock split, ex-date: 08 Aug 18", "dt": "2018-08-08", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Fermenta Biotech Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 13 Feb 20", "dt": "2020-02-13", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: Stock opens at Rs.302.00, declines despite Sensex rally

26 May: Death Cross forms, stock drops 3.77% to Rs.290.60

27 May: Q4 FY26 results reveal profit plunge; technical downgrade confirmed

29 May: Stock recovers slightly to Rs.295.20 but remains under pressure

Week Open

Rs.302.65

Week CloseRead full news article

Are Fermenta Biotech Ltd latest results good or bad?

2026-05-27 19:39:18

Fermenta Biotech Ltd's latest financial results for the quarter ended March 2026 indicate significant challenges in operational performance. The company reported consolidated net sales of ₹121.58 crores, reflecting a year-on-year decline of 13.06% from ₹139.85 crores in the same quarter of the previous year. This marks the fourth consecutive quarter of year-on-year revenue decline, with the current quarter showing the steepest drop. Consolidated net profit also faced substantial pressure, amounting to ₹19.19 crores, which represents a 44.20% decrease compared to the previous year. While there was a sequential recovery in net profit, the year-on-year performance highlights ongoing difficulties in maintaining profitability. The operating profit, excluding other income, fell sharply to ₹20.00 crores, down 45.86% from ₹36.94 crores in the prior year, indicating significant margin compression. Operating margin...

Read full news article

Fermenta Biotech Q4 FY26: Profitability Plunges Amid Revenue Decline

2026-05-27 12:02:10

Fermenta Biotech Limited, a micro-cap pharmaceutical and biotechnology company, reported a challenging fourth quarter for FY26, with consolidated net profit declining 44.20% year-on-year to ₹19.19 crores from ₹34.39 crores in Q4 FY25. On a sequential basis, however, the company managed a 51.34% quarter-on-quarter recovery from the ₹12.68 crores posted in Q3 FY26. Net sales for the quarter stood at ₹121.58 crores, down 13.06% year-on-year and 11.49% sequentially, marking the lowest quarterly revenue in the past eight quarters.

Read full news article

Fermenta Biotech Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-05-27 08:00:55

Fermenta Biotech Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s stock price has declined by 3.77% today, reflecting growing investor caution amid weakening technical parameters and a downgrade in its overall mojo grade to Strong Sell.

Read full news article